Browsing Tag
neuromodulation
8 posts
MeRT FDA clearance gives Wave Neuroscience a first-mover role in biomarker-guided PTSD care
Find out how Wave Neuroscience’s MeRT FDA clearance could reshape biomarker-guided neuromodulation for PTSD care.
How the gammaCore PTSD study may influence bioelectronic medicine adoption in mental health
Can gammaCore’s PTSD study accelerate bioelectronic medicine adoption in mental health? Read what this means for electroCore, Inc. and the sector.
Resonetics closes Resolution Medical deal, targeting full-stack dominance in neuromodulation and structural heart
Resonetics completes acquisition of Resolution Medical, adding biosimulation and finished device assembly to its neuromodulation and structural heart platform. Read the full analysis.
Soin Neuroscience and BIOTRONIK Neuro target SCS personalization with novel waveform collaboration
Find out how Soin Neuroscience and BIOTRONIK Neuro are using adaptive waveforms to personalize spinal cord stimulation therapy for chronic pain.
Breakthrough: FDA grants NeurAxis first-ever clearance for adult functional dyspepsia pain and nausea
Discover how NeurAxis’s newly FDA-cleared PENFS therapy is changing treatment for adults with functional dyspepsia pain and nausea.
Boston Scientific to take full control of Nalu Medical in $533m chronic pain tech deal
Boston Scientific is acquiring Nalu Medical for $533M to expand its pain therapy portfolio with a miniaturized, wearable neurostimulation system. Learn what this means.
VIVATRONIX and SpineX secure CDSCO approval for xStep device: Can India’s new neuromodulation era transform paralysis care?
India approves VIVATRONIX–SpineX xStep device for paralysis care—marking a major leap for noninvasive neuromodulation and India’s medtech future.
Is neuromodulation entering its next growth cycle? Lessons from Medtronic, Axonics, and Boston Scientific
Neuromodulation is moving into its next growth cycle. Explore how Medtronic, Boston Scientific, and Axonics are reshaping bladder control and chronic care.